SCHEDULE: Morgan Stanley Amends Stake in Guggenheim Active Allocation Fund
Beneficial Ownership Amendment
Morgan Stanley and its subsidiary, Morgan Stanley Smith Barney LLC, have filed an Amendment No. 3 to their Schedule 13G, disclosing an 8.4% beneficial ownership in Guggenheim Active Allocation Fund.
Summary
- Morgan Stanley and Morgan Stanley Smith Barney LLC are reporting beneficial ownership in Guggenheim Active Allocation Fund.
- Morgan Stanley beneficially owns 2,777,696.00 common shares, representing 8.4% of the class.
- Morgan Stanley Smith Barney LLC beneficially owns 2,775,942.00 common shares, also representing 8.4% of the class.
- The filing is an Amendment No. 3 to a Schedule 13G, indicating an update to previous ownership disclosures.
- The date of the event requiring this filing is September 30, 2025.
- Morgan Stanley Smith Barney LLC is identified as a wholly-owned subsidiary of Morgan Stanley.
Sentiment
Score: 5
Explanation: Neutral, as this is a factual disclosure of beneficial ownership without performance or operational details of the issuer.
Positives
- Disclosure of significant institutional ownership by Morgan Stanley, a major financial institution, in Guggenheim Active Allocation Fund.
Future Outlook
NA
Industry Context
This filing reflects a standard disclosure of significant beneficial ownership by a major financial institution in an investment fund, common in the asset management and investment banking sectors. Such disclosures provide transparency regarding institutional investment positions.
Stakeholder Impact
- Shareholders of Guggenheim Active Allocation Fund: Provides transparency regarding significant institutional holders, which can influence market perception and liquidity.
- Morgan Stanley: Discloses its investment position in the fund.
Key Dates
| Date | Description |
|---|---|
| 09/30/2025 | Date of event which requires filing of this statement. |
| 11/07/2025 | Signature date for Morgan Stanley and Morgan Stanley Smith Barney LLC. |
Keywords
Morgan Stanley, Guggenheim Active Allocation Fund, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Shares, Investment Fund, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.